GLI1 and neoplasm: GLI activation upregulated the expression of VEGF and NRP2 in transgenic tumors of mouse models, which in turn induced α6β1 integrin-mediated activation of RAS/MEK signaling through focal adhesion kinase (FAK) activation to enhance GLI1 expression and promote tumor-initiating or CSC-like properties [93].